Novartis AG

Common Name

Novartis

Country

Switzerland

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

103,000

Ticker

NOVN

Exchange

SIX SWISS EXCHANGE

Website

www.novartis.com

Description

Novartis AG is a global healthcare company that operates in the pharmaceuticals and biotechnology sectors. Its primary function is to research, develop, and manufacture healthcare products, with a foc... Show more

Financial Statements of Novartis

Below are the financial statements of Novartis, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of USD	2024	2023	2022
Net sales from continuing operations	50,317^a	45,440^a	42,206^a
Other revenues	1,405^a	1,220^a	1,255^a
Cost of goods sold	-12,827^a	-12,472^a	-11,582^a
Gross profit from continuing operations	38,895^a	34,188^a	31,879^a
Selling, general and administration	-12,566^a	-12,517^a	-12,193^a
Research and development	-10,022^a	-11,371^a	-9,172^a
Other income	1,175^a	1,772^a	696^a
Other expense	-2,938^a	-2,303^a	-3,264^a
Operating income from continuing operations	14,544^a	9,769^a	7,946^a
Loss from associated companies	-38^a	-13^a	-11^a
Interest expense	-1,006^a	-855^a	-800^a
Other financial income and expense	140^a	222^a	42^a
Income before taxes from continuing operations	13,640^a	9,123^a	7,177^a
Income taxes	-1,701^a	-551^a	-1,128^a
Net income from continuing operations	11,939^a	8,572^a	6,049^a
Net income from discontinued operations before gain on distribution of Sandoz Group AG to Novartis AG shareholders	0^a	422^a	906^a
Gain on distribution of Sandoz Group AG to Novartis AG shareholders	0^a	5,860^a	0^a
Net income from discontinued operations	0^a	6,282^a	906^a
Net income	11,939^a	14,854^a	6,955^a
Attributable to	—	—	—
Shareholders of Novartis AG	11,941^a	14,850^a	6,955^a
Non-controlling interests	-2^a	4^a	0^a

Download Data

Verified Sources Behind Novartis’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Novartis’s data sources below and access millions more through our Disclosure Search.

a. Novartis's Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Novartis AG

Financial Statements of Novartis

Verified Sources Behind Novartis’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Roche Holding AG

Lonza Group AG

Tecan Group AG

BeOne Medicines AG

Galenica AG

Straumann Holding AG